HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Clayer Selected Research

Ephrin-B1 (Ephrin B1)

8/2002Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Clayer Research Topics

Disease

3Osteosarcoma (Osteogenic Sarcoma)
04/2015 - 06/2002
3Neoplasms (Cancer)
07/2008 - 06/2002
1Bursitis (Adhesive Capsulitis)
11/2014
1Arthritis (Polyarthritis)
11/2014
1Infections
11/2010
1Chondrosarcoma
09/2009
1Aneurysmal Bone Cysts
05/2008
1Melanoma (Melanoma, Malignant)
08/2002
1Breast Neoplasms (Breast Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

1Antirheumatic Agents (DMARD)IBA
11/2014
1Calcium Sulfate (Alabaster)IBA
05/2008
1Messenger RNA (mRNA)IBA
08/2002
1Ephrin-B3 (Ephrin B3)IBA
08/2002
1LigandsIBA
08/2002
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2002
1Proteins (Proteins, Gene)FDA Link
08/2002
1Ephrin-A5 (AL-1)IBA
08/2002
1Ephrin-B1 (Ephrin B1)IBA
08/2002
1Ephrin-B2 (Ephrin B2)IBA
08/2002
1EphA1 Receptor (Eph Receptor)IBA
08/2002
1EphrinsIBA
08/2002
1Ephrin-A1 (Ephrin A1)IBA
08/2002
1Ephrin-A3 (Ephrin A3)IBA
08/2002
1Ephrin-A4 (Ephrin A4)IBA
08/2002
1CytokinesIBA
06/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2002

Therapy/Procedure

1Neoadjuvant Therapy
04/2015
1Reoperation
11/2010
1Surgical Amputation (Amputations)
09/2009
1Limb Salvage
07/2008
1Injections
05/2008
1Therapeutics
06/2002
1Drug Therapy (Chemotherapy)
06/2002